- Home
- VIVS vs SGLY Comparison
VIVS vs SGLY Comparison
Compare VIVS & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- SGLY
- Stock Information
- Founded
- VIVS 2007
- SGLY 2001
- Country
- VIVS United States
- SGLY United States
- Employees
- VIVS N/A
- SGLY N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- SGLY
- Sector
- VIVS Health Care
- SGLY
- Exchange
- VIVS Nasdaq
- SGLY Nasdaq
- Market Cap
- VIVS 4.7M
- SGLY 4.5M
- IPO Year
- VIVS N/A
- SGLY 2008
- Fundamental
- Price
- VIVS $3.64
- SGLY $1.29
- Analyst Decision
- VIVS
- SGLY
- Analyst Count
- VIVS 0
- SGLY 0
- Target Price
- VIVS N/A
- SGLY N/A
- AVG Volume (30 Days)
- VIVS 868.7K
- SGLY 61.9K
- Earning Date
- VIVS 11-07-2025
- SGLY 11-13-2025
- Dividend Yield
- VIVS N/A
- SGLY N/A
- EPS Growth
- VIVS N/A
- SGLY N/A
- EPS
- VIVS N/A
- SGLY N/A
- Revenue
- VIVS $142,000.00
- SGLY $2,172,036.00
- Revenue This Year
- VIVS $42.38
- SGLY N/A
- Revenue Next Year
- VIVS $15.42
- SGLY N/A
- P/E Ratio
- VIVS N/A
- SGLY N/A
- Revenue Growth
- VIVS 94.52
- SGLY N/A
- 52 Week Low
- VIVS $1.41
- SGLY $0.54
- 52 Week High
- VIVS $21.96
- SGLY $5.49
- Technical
- Relative Strength Index (RSI)
- VIVS 62.00
- SGLY 69.39
- Support Level
- VIVS $3.29
- SGLY $1.11
- Resistance Level
- VIVS $5.30
- SGLY $1.21
- Average True Range (ATR)
- VIVS 0.63
- SGLY 0.09
- MACD
- VIVS 0.16
- SGLY 0.01
- Stochastic Oscillator
- VIVS 52.16
- SGLY 68.63
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.